ATE180967T1 - Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür - Google Patents

Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür

Info

Publication number: ATE180967T1
Authority: AT; Austria
Prior art keywords: horserad; functional disorder; preparation therefor; sinus; treating nose
Prior art date: 1992-03-02

Application number

AT93906980T

Other languages

English (en)

Inventor

William H Friedman

Original Assignee

William H Friedman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-02

Filing date

1993-02-19

Publication date

1999-06-15

1993-02-19 Application filed by William H Friedman filed Critical William H Friedman

1999-06-15 Application granted granted Critical

1999-06-15 Publication of ATE180967T1 publication Critical patent/ATE180967T1/de

Links

238000002360 preparation method Methods 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 2
ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 abstract 4
PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 abstract 2
235000011330 Armoracia rusticana Nutrition 0.000 abstract 2
240000003291 Armoracia rusticana Species 0.000 abstract 2
PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 abstract 2
235000016720 allyl isothiocyanate Nutrition 0.000 abstract 2
230000004064 dysfunction Effects 0.000 abstract 2
QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 abstract 2
235000017291 sinigrin Nutrition 0.000 abstract 2
210000004877 mucosa Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Mycology (AREA)
Microbiology (AREA)
Inorganic Chemistry (AREA)
Dispersion Chemistry (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT93906980T 1992-03-02 1993-02-19 Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür ATE180967T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/844,107 US5248504A (en)	1992-03-02	1992-03-02	Method of treatment for nasal and sinus dysfunction

Publications (1)

Publication Number	Publication Date
ATE180967T1 true ATE180967T1 (de)	1999-06-15

Family

ID=25291834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93906980T ATE180967T1 (de)	1992-03-02	1993-02-19	Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür

Country Status (8)

Country	Link
US (2)	US5248504A (de)
EP (1)	EP0630232B1 (de)
JP (1)	JPH07504436A (de)
KR (1)	KR950700077A (de)
AT (1)	ATE180967T1 (de)
CA (1)	CA2131458A1 (de)
DE (1)	DE69325265D1 (de)
WO (1)	WO1993017666A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996002275A1 (en) *	1994-07-20	1996-02-01	Toyama Chemical Co., Ltd.	Sustained-release oral ointment
US5686108A (en) *	1995-09-27	1997-11-11	Amway Corporation	Brassica vegetable supplement and process for manufacture
DE69838338T2 (de)	1997-10-22	2008-05-21	Jens Rochester Ponikau	Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
US20010053775A1 (en) *	1998-01-30	2001-12-20	Matthias Seidel	Nasal solutions
US6164278A (en) *	1999-02-25	2000-12-26	Nissani; Moti	Taste-based approach to the prevention of teeth clenching and grinding
US20040046440A1 (en) *	2001-12-14	2004-03-11	Daniel Brinker	Knuckle hub assembly and method for making same
US6355262B1 (en)	1999-08-30	2002-03-12	Sigmund Krentz	Liniment for topical application
US6592896B2 (en)	2001-08-06	2003-07-15	The Quigley Corporation	Medicinal composition and method of using it
US7166435B2 (en)	2001-08-06	2007-01-23	The Quigley Corporation	Compositions and methods for reducing the transmissivity of illnesses
US6596313B2 (en)	2001-08-06	2003-07-22	The Quigley Corporation	Nutritional supplement and methods of using it
US7396546B2 (en) *	2001-08-06	2008-07-08	The Quigley Corporation	Anti-microbial compositions and methods of using same
US20040019316A1 (en) *	2002-03-13	2004-01-29	Morris John K.	Nasal airway delivery, decongestion system (NADDS)
WO2004037244A1 (en) *	2002-09-25	2004-05-06	Andrea Marinello	Apparatus for the treatment of maxillary and frontal sinusitis and neuritis and neuralgia of the trigeminal nerve
US20040235807A1 (en) *	2003-05-21	2004-11-25	Weinrich Karl P.	Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US7507425B2 (en) *	2005-09-27	2009-03-24	The Quigley Corporation	Method for the treatment of cachexia
US20080038386A1 (en) *	2006-08-02	2008-02-14	Ashok K Moza	Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition
DE502008002360D1 (de) *	2007-06-19	2011-03-03	Symrise Ag	Aromakomposition zum Verringern oder Unterdrücken von unerwünschtem bitteren und adstringierenden Eindruck
GB201010418D0 (en) *	2010-06-22	2010-08-04	Univ Warwick	Prevention of proteomic and genomic damage by dicarbonyl substrates of Glo1
WO2012074922A1 (en) *	2010-11-29	2012-06-07	Security Equipment Corporation	Defense spray using isothiocyanate as an ingredient
US10640464B2 (en)	2011-01-03	2020-05-05	The William M. Yarbrough Foundation	Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10273205B2 (en)	2011-01-03	2019-04-30	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US8933119B2 (en)	2011-01-03	2015-01-13	The William M. Yarbrough Foundation	Method for treating phytophotodermatitis
US11407713B2 (en)	2011-01-03	2022-08-09	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en)	2011-01-03	2020-05-12	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en)	2011-01-03	2018-05-08	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11279674B2 (en)	2011-01-03	2022-03-22	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US10308599B2 (en)	2011-01-03	2019-06-04	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en)	2011-01-12	2014-10-21	The William M. Yarbrough Foundation	Method for treating eczema
US9532969B2 (en)	2011-02-08	2017-01-03	The William M. Yarbrough Foundation	Method for treating psoriasis
US9839621B2 (en)	2012-07-26	2017-12-12	The William M. Yarbrough Foundation	Method for treating bladder cancer
WO2014018874A1 (en)	2012-07-26	2014-01-30	The William M. Yarbrough Foundation	Method for treating skin cancer
US10335387B2 (en)	2012-07-26	2019-07-02	The William M. Yarbrough Foundation	Method for treating infectious diseases with isothiocyanate functional compounds
US9949943B2 (en)	2012-07-26	2018-04-24	The William M. Yarbrough Foundation	Method for treating neurodegenerative diseases
US10441561B2 (en)	2012-07-26	2019-10-15	The William M. Yanbrough Foundation	Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434081B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Inhibitors of macrophage migration inhibitory factor
US10080734B2 (en)	2012-07-26	2018-09-25	The William M. Yarbrough Foundation	Method for treating autism and other neurodevelopmental disorders
US10434082B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US71549A (en) *		1867-11-26		Executrix
US74205A (en) *		1868-02-11		Chaeles a
US63965A (en) *		1867-04-16		Thomas l
US28904A (en) *		1860-06-26		Medical compound
US378504A (en) *		1888-02-28		Catarrh remedy
US98875A (en) *		1870-01-18		Peter mays and price mays
US153933A (en) *		1874-08-11		Improvement in compounds for cough-sirup
DE974171C (de) *	1954-02-06	1960-10-06	Rolf Opitz	Verfahren zur Herstellung eines Rettichpraeparates
US3781424A (en) *	1970-07-21	1973-12-25	E Ponvert	Hemorrhoid treatment preparation produced from hot cherry peppers
DE2063845A1 (de) *	1970-12-24	1972-06-29	Vujcuf, Josef, 8000 München	Antidiabetisches Pflanzenpräparat
HU181559B (en) *	1980-04-28	1983-10-28	Herbaria Orszagos Gyogynoeveny	Composition for promoting the growth of the hair and stimulating the hair with improved characteristics and process for its preparation
US4782023A (en) *	1984-02-03	1988-11-01	Abbott Laboratories	Stabilized horseradish peroxidase conjugate composition
US5059421A (en) *	1985-07-26	1991-10-22	The Liposome Company, Inc.	Preparation of targeted liposome systems of a defined size distribution
EP0262344B1 (de) *	1986-08-07	1996-03-27	MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG	N-alkylierte quartäre stickstoffhaltige Heterozyklen, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
US4767612A (en) *	1987-01-23	1988-08-30	Rorer Pharmaceutical Corporation	Triamcinolone acetonide for the treatment of allergic rhinitis
US4944941A (en) *	1987-08-07	1990-07-31	Genentech, Inc.	Methods and compositions for the treatment of lung conditions
US5114969A (en) *	1989-03-22	1992-05-19	American Health Foundation	Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same

1992
- 1992-03-02 US US07/844,107 patent/US5248504A/en not_active Expired - Fee Related
1993
- 1993-02-19 JP JP5515704A patent/JPH07504436A/ja active Pending
- 1993-02-19 AT AT93906980T patent/ATE180967T1/de not_active IP Right Cessation
- 1993-02-19 EP EP93906980A patent/EP0630232B1/de not_active Expired - Lifetime
- 1993-02-19 CA CA002131458A patent/CA2131458A1/en not_active Abandoned
- 1993-02-19 KR KR1019940703072A patent/KR950700077A/ko not_active Ceased
- 1993-02-19 WO PCT/US1993/001491 patent/WO1993017666A1/en not_active Ceased
- 1993-02-19 DE DE69325265T patent/DE69325265D1/de not_active Expired - Lifetime
- 1993-05-27 US US08/068,998 patent/US5385734A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR950700077A (ko)	1995-01-16
WO1993017666A1 (en)	1993-09-16
JPH07504436A (ja)	1995-05-18
EP0630232A4 (de)	1995-07-12
EP0630232B1 (de)	1999-06-09
US5385734A (en)	1995-01-31
CA2131458A1 (en)	1993-09-16
EP0630232A1 (de)	1994-12-28
US5248504A (en)	1993-09-28
DE69325265D1 (de)	1999-07-15

Legal Events

Date	Code	Title	Description
1999-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE180967T1 (de)	1999-06-15	Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür
EP0259440A4 (de)	1989-11-07	Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
BG99261A (en)	1995-06-30	Steroid glycosides for the treatment of hyperchlesterolemia
DE3684190D1 (de)	1992-04-16	Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE196082T1 (de)	2000-09-15	Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
DE3587741D1 (de)	1994-03-17	Behandlung von Hautkrankheiten.
BR9806989A (pt)	2000-03-14	Processo para tratar a epiderme ou membrana da mucosa de um indivìduo mamìfero.
DE3888205D1 (de)	1994-04-07	Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
ATE258796T1 (de)	2004-02-15	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69807349D1 (de)	2002-09-26	Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
DE3789082D1 (de)	1994-03-24	Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
DK71387A (da)	1987-08-25	Terapeutisk middel til behandling af psoriasis
DE3584560D1 (de)	1991-12-05	Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
FI881877A0 (fi)	1988-04-21	17 -(cyklopropylamino) androst-5 -en-3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20-lyas-inhibitorer.
DE3650620D1 (de)	1997-06-12	Behandlungsverfahren kataboler dysfunktion
EP1274414A4 (de)	2007-08-22	Nasale verabreichung von mitteln zur behandlung von gastroparese
ATE239468T1 (de)	2003-05-15	Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE217191T1 (de)	2002-05-15	Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE81006T1 (de)	1992-10-15	Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.
ATE202935T1 (de)	2001-07-15	Verfahren zur behandlung von haarausfall
ATE308337T1 (de)	2005-11-15	Hgf zur behandlung von akutem nierenversagen
EP1056458A4 (de)	2001-06-20	Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE69218200D1 (de)	1997-04-17	Behandlung von leberkrebs
DE69729201T2 (de)	2005-04-21	Sulfonfluoride zur behandlung von der alzheimerischen krankheit